Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Small phenolic compounds as potential endocrine disruptors interacting with estrogen receptor alpha

R. Alva-Gallegos, E. Jirkovský, P. Mladěnka, A. Carazo

. 2024 ; 15 (-) : 1440654. [pub] 20241024

Language English Country Switzerland

Document type Journal Article

The human body is regularly exposed to simple catechols and small phenols originating from our diet or as a consequence of exposure to various industrial products. Several biological properties have been associated with these compounds such as antioxidant, anti-inflammatory, or antiplatelet activity. Less explored is their potential impact on the endocrine system, in particular through interaction with the alpha isoform of the estrogen receptor (ERα). In this study, human breast cancer cell line MCF-7/S0.5 was employed to investigate the effects on ERα of 22 closely chemically related compounds (15 catechols and 7 phenols and their methoxy derivatives), to which humans are widely exposed. ERα targets genes ESR1 (ERα) and TFF1, both on mRNA and protein level, were chosen to study the effect of the tested compounds on the mentioned receptor. A total of 7 compounds seemed to impact mRNA and protein expression similarly to estradiol (E2). The direct interaction of the most active compounds with the ERα ligand binding domain (LBD) was further tested in cell-free experiments using the recombinant form of the LBD, and 4-chloropyrocatechol was shown to behave like E2 with about 1/3 of the potency of E2. Our results provide evidence that some of these compounds can be considered potential endocrine disruptors interacting with ERα.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25003802
003      
CZ-PrNML
005      
20250206104719.0
007      
ta
008      
250121e20241024sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fendo.2024.1440654 $2 doi
035    __
$a (PubMed)39512757
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Alva-Gallegos, Raul $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czechia
245    10
$a Small phenolic compounds as potential endocrine disruptors interacting with estrogen receptor alpha / $c R. Alva-Gallegos, E. Jirkovský, P. Mladěnka, A. Carazo
520    9_
$a The human body is regularly exposed to simple catechols and small phenols originating from our diet or as a consequence of exposure to various industrial products. Several biological properties have been associated with these compounds such as antioxidant, anti-inflammatory, or antiplatelet activity. Less explored is their potential impact on the endocrine system, in particular through interaction with the alpha isoform of the estrogen receptor (ERα). In this study, human breast cancer cell line MCF-7/S0.5 was employed to investigate the effects on ERα of 22 closely chemically related compounds (15 catechols and 7 phenols and their methoxy derivatives), to which humans are widely exposed. ERα targets genes ESR1 (ERα) and TFF1, both on mRNA and protein level, were chosen to study the effect of the tested compounds on the mentioned receptor. A total of 7 compounds seemed to impact mRNA and protein expression similarly to estradiol (E2). The direct interaction of the most active compounds with the ERα ligand binding domain (LBD) was further tested in cell-free experiments using the recombinant form of the LBD, and 4-chloropyrocatechol was shown to behave like E2 with about 1/3 of the potency of E2. Our results provide evidence that some of these compounds can be considered potential endocrine disruptors interacting with ERα.
650    _2
$a lidé $7 D006801
650    12
$a alfa receptor estrogenů $x metabolismus $x genetika $7 D047628
650    12
$a endokrinní disruptory $x farmakologie $x toxicita $7 D052244
650    12
$a fenoly $x farmakologie $x chemie $7 D010636
650    _2
$a MFC-7 buňky $7 D061986
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a nádory prsu $x metabolismus $7 D001943
650    _2
$a faktor TFF1 $x metabolismus $x genetika $7 D000071163
655    _2
$a časopisecké články $7 D016428
700    1_
$a Jirkovský, Eduard $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czechia
700    1_
$a Mladěnka, Přemysl $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czechia
700    1_
$a Carazo, Alejandro $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czechia
773    0_
$w MED00174543 $t Frontiers in endocrinology $x 1664-2392 $g Roč. 15 (20241024), s. 1440654
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39512757 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206104714 $b ABA008
999    __
$a ok $b bmc $g 2263526 $s 1239809
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 15 $c - $d 1440654 $e 20241024 $i 1664-2392 $m Frontiers in endocrinology $n Front Endocrinol (Lausanne) $x MED00174543
LZP    __
$a Pubmed-20250121

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...